Skip to main content
Top
Published in: Pediatric Rheumatology 1/2019

Open Access 01-12-2019 | Echocardiography | Research article

Screening of asymptomatic rheumatic heart disease among refugee/migrant children and youths in Italy

Authors: Fortunata Condemi, Gabriele Rossi, Miguel Lupiz, Antonio Pagano, Federica Zamatto, Stefano Marini, Francesco Romeo, Gianfranco De Maio

Published in: Pediatric Rheumatology | Issue 1/2019

Login to get access

Abstract

Background

Rheumatic heart disease (RHD) is a chronic condition responsible of congestive heart failure, stroke and arrhythmia. Almost eradicated in high-income countries (HIC), it persists in low- and middle-income countries. The purpose of the study was to assess the feasibility and meaningfulness of ultrasound-based RHD screening among the population of unaccompanied foreign minors in Italy and determine the burden of asymptomatic RHD among this discrete population.

Methods

From February 2016 to January 2018, Médecins Sans Frontières conducted a weekly mobile screening by echocardiography in reception centers and family houses for unaccompanied foreign minors in Rome, followed by fix echocardiographic retesting for those resulting positive at screening. ‘Definite’ and ‘borderline’ cases were defined according to the World Hearth Federation criteria.

Results

Six hundred fifty-three individuals (13–26 years old) were screened; 95.6% were below 18 years old (624/653). Six ‘definite RHD’ were identified at screening, yielding a detection rate of 9.2‰ (95% CI 4.1–20.3‰), while 285 (436.4‰) were defined as ‘borderline’ (95% CI 398.8–474.9‰). Out of 172 “non-negative borderline” cases available for being retested (113 “non-negative borderline” lost in follow-up), additional 11 were categorized as ‘definite RHD’, for a total of 17 ‘definite RHD’, yielding a final prevalence of 26.0‰ (95% CI 16.2–41.5‰) (17/653), and 122 (122/653) were confirmed as ‘borderline’ (final prevalence of 186.8‰, 95% CI 158.7–218.7). In multivariate logistic regression analysis the presence of systolic murmur was a strong predictor for both ‘borderline’ (OR 4.3 [2.8–6.5]) and ‘definite RHD’ (OR 5.2 [1.7–15.2]), while no specific country/geographic area of origin was statistically associated with an increased risk of latent, asymptomatic RHD.

Conclusions

Screening for RHD among the unaccompanied migrant minors in Italy proved to be feasible. The burden of ‘definite RHD’ was similar to that identified in resource-poor settings, while the prevalence of ‘borderline’ cases was higher than reported in other studies. In view of these findings, the health system of high-income countries, hosting migrants and asylum seekers, are urged to adopt screening for RHD in particular among the silent and marginalized population of refugee and migrant children.
Literature
1.
go back to reference Watkins DA, Beaton AZ, Carapetis JR, Karthikeyan G, Mayosi BM, Wyber R, et al. Rheumatic heart disease worldwide: JACC scientific expert panel. J Am Coll Cardiol. 2018;72:1397–416.CrossRef Watkins DA, Beaton AZ, Carapetis JR, Karthikeyan G, Mayosi BM, Wyber R, et al. Rheumatic heart disease worldwide: JACC scientific expert panel. J Am Coll Cardiol. 2018;72:1397–416.CrossRef
2.
go back to reference GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all–cause and cause–specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–71.CrossRef GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all–cause and cause–specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–71.CrossRef
3.
go back to reference Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clinical Epidemiology. 2011;3:67–84.CrossRef Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clinical Epidemiology. 2011;3:67–84.CrossRef
4.
go back to reference Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357:470–6.CrossRef Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357:470–6.CrossRef
5.
go back to reference Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G et al. Global, regional and national burden of rheumatic heart disease 1990 - 2015 2017 N Engl J Med 2017;377:713–22. Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G et al. Global, regional and national burden of rheumatic heart disease 1990 - 2015 2017 N Engl J Med 2017;377:713–22.
6.
go back to reference Rothenbühler M, O'Sullivan CJ, Stortecky S, Stefanini GG, Spitzer E, Estill J, et al. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta–analysis of prevalence among children and adolescents. Lancet Glob Health. 2014;2:e717–26.CrossRef Rothenbühler M, O'Sullivan CJ, Stortecky S, Stefanini GG, Spitzer E, Estill J, et al. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta–analysis of prevalence among children and adolescents. Lancet Glob Health. 2014;2:e717–26.CrossRef
7.
go back to reference Rossi E, Felici AR, Banteyrga L. Subclinical rheumatic heart disease in an Eritrean high-school population, detected by echocardiography. J Heart Valve Dis. 2014;23:235–9.PubMed Rossi E, Felici AR, Banteyrga L. Subclinical rheumatic heart disease in an Eritrean high-school population, detected by echocardiography. J Heart Valve Dis. 2014;23:235–9.PubMed
8.
go back to reference Kotit S, Said K, ElFaramawy A, Mahmoud H, Phillips DIW, Yacoub M. Prevalence and prognostic value of echocardiographic screening for rheumatic heart disease. Open Heart. 2017;4(2):e000702.CrossRef Kotit S, Said K, ElFaramawy A, Mahmoud H, Phillips DIW, Yacoub M. Prevalence and prognostic value of echocardiographic screening for rheumatic heart disease. Open Heart. 2017;4(2):e000702.CrossRef
12.
go back to reference Rossi G, Lee VSW. Call for preventive care for rheumatic heart disease in refugee children. BMJ. 2016;353:i2312.CrossRef Rossi G, Lee VSW. Call for preventive care for rheumatic heart disease in refugee children. BMJ. 2016;353:i2312.CrossRef
15.
go back to reference Grimaldi A, Vermi AC, Cammalleri V, castiglioni A, Pappalardo F, Taramasso M, et al. Heart surgery for immigrants in Italy: burden of cardiovascular disease, adherence to treatment and outcomes. Journal of Cardiovascular Medicine. 2016;17:105–12.CrossRef Grimaldi A, Vermi AC, Cammalleri V, castiglioni A, Pappalardo F, Taramasso M, et al. Heart surgery for immigrants in Italy: burden of cardiovascular disease, adherence to treatment and outcomes. Journal of Cardiovascular Medicine. 2016;17:105–12.CrossRef
17.
18.
go back to reference Remenyi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al. World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease –an evidence-based guideline. Nat Rev Cardiol. 2012;9:297–309.CrossRef Remenyi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al. World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease –an evidence-based guideline. Nat Rev Cardiol. 2012;9:297–309.CrossRef
19.
go back to reference Australia RHD. Australian guidelines for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. 2nd ed: National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand; 2012. Australia RHD. Australian guidelines for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. 2nd ed: National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand; 2012.
20.
go back to reference Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002;3:CD002227. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002;3:CD002227.
21.
go back to reference Zuhlke L, Mayosi BM. Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep. 2013;15:343.CrossRef Zuhlke L, Mayosi BM. Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep. 2013;15:343.CrossRef
22.
go back to reference Grayson S, Horsburgh M, Lennon D. An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J. 2006;119(1243). Grayson S, Horsburgh M, Lennon D. An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J. 2006;119(1243).
23.
go back to reference Hunter LD, Monaghan M, Lloyd G, Pecoraro AJK, Doubell AF, Herbst PG. Screening for rheumatic heart disease: is a paradigm shift required? Echo Res Pract. 2017;4:R43–52.CrossRef Hunter LD, Monaghan M, Lloyd G, Pecoraro AJK, Doubell AF, Herbst PG. Screening for rheumatic heart disease: is a paradigm shift required? Echo Res Pract. 2017;4:R43–52.CrossRef
24.
go back to reference Rémond M, Atkinson D, White A, Brown A, Carapetis J, Remenyi B, Roberts K, et al. Are minor echocardiographic changes associated with an increased risk of acute rheumatic fever or progression to rheumatic heart disease? Int J Cardiol. 2015;198:117–22.CrossRef Rémond M, Atkinson D, White A, Brown A, Carapetis J, Remenyi B, Roberts K, et al. Are minor echocardiographic changes associated with an increased risk of acute rheumatic fever or progression to rheumatic heart disease? Int J Cardiol. 2015;198:117–22.CrossRef
25.
go back to reference Bertaina G, Rouchon B, Huon B, Guillot N, Robillard C, Noel B, et al. Outcomes of borderline rheumatic heart disease: a prospective cohort study. Int J Cardiol. 2017;228:661–5.CrossRef Bertaina G, Rouchon B, Huon B, Guillot N, Robillard C, Noel B, et al. Outcomes of borderline rheumatic heart disease: a prospective cohort study. Int J Cardiol. 2017;228:661–5.CrossRef
26.
go back to reference Beaton A, Aliku T, Dewyer A, Jacobs M, Jiang J, Longenecker CT, et al. Latent rheumatic heart disease. Identifying the children at highest risk of unfavourable outcome. Circulation. 2017;136:2233–44.CrossRef Beaton A, Aliku T, Dewyer A, Jacobs M, Jiang J, Longenecker CT, et al. Latent rheumatic heart disease. Identifying the children at highest risk of unfavourable outcome. Circulation. 2017;136:2233–44.CrossRef
27.
go back to reference Zühlke L, Engel ME, Lemmer CE, van de Wall M, Nkepu S, Meiring A, et al. The natural history of latent rheumatic heart disease in a 5 year follow–up study: a prospective observational study. BMC Cardiovasc Disord. 2016;16:46.CrossRef Zühlke L, Engel ME, Lemmer CE, van de Wall M, Nkepu S, Meiring A, et al. The natural history of latent rheumatic heart disease in a 5 year follow–up study: a prospective observational study. BMC Cardiovasc Disord. 2016;16:46.CrossRef
28.
go back to reference Dougherty S, Khorsandi M, Herbst PG, et al. Rheumatic heart disease screening: current concepts and challenges. Ann Pediatr Cardiol. 2017;10:39–49.CrossRef Dougherty S, Khorsandi M, Herbst PG, et al. Rheumatic heart disease screening: current concepts and challenges. Ann Pediatr Cardiol. 2017;10:39–49.CrossRef
31.
go back to reference James N, Kirkpatrick JN, Otto CM. Clinical impact and costs of echocardiographic screening for rheumatic heart disease. J Am Heart Assoc. 2017;6:e005666. James N, Kirkpatrick JN, Otto CM. Clinical impact and costs of echocardiographic screening for rheumatic heart disease. J Am Heart Assoc. 2017;6:e005666.
32.
go back to reference Marijon E, Celermajer DS, Jouven X. Rheumatic heart disease - an iceberg in tropical waters. N Engl J Med. 2017;377(8):780–1.CrossRef Marijon E, Celermajer DS, Jouven X. Rheumatic heart disease - an iceberg in tropical waters. N Engl J Med. 2017;377(8):780–1.CrossRef
Metadata
Title
Screening of asymptomatic rheumatic heart disease among refugee/migrant children and youths in Italy
Authors
Fortunata Condemi
Gabriele Rossi
Miguel Lupiz
Antonio Pagano
Federica Zamatto
Stefano Marini
Francesco Romeo
Gianfranco De Maio
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2019
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-019-0314-9

Other articles of this Issue 1/2019

Pediatric Rheumatology 1/2019 Go to the issue